BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 31903117)

  • 1. Soluble CD146, a cerebrospinal fluid marker for neuroinflammation, promotes blood-brain barrier dysfunction.
    Wang D; Duan H; Feng J; Xiang J; Feng L; Liu D; Chen X; Jing L; Liu Z; Zhang D; Hao H; Yan X
    Theranostics; 2020; 10(1):231-246. PubMed ID: 31903117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High Level of Soluble CD146 In Cerebrospinal Fluid Might be a Biomarker of Severity of Anti-N-Methyl-D-Aspartate Receptor Encephalitis.
    Li Q; Chen J; Yin M; Zhao J; Lu F; Wang Z; Yu X; Wang S; Zheng D; Wang H
    Front Immunol; 2021; 12():680424. PubMed ID: 34220828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble CD146 in cerebrospinal fluid of active multiple sclerosis.
    Duan H; Luo Y; Hao H; Feng L; Zhang Y; Lu D; Xing S; Feng J; Yang D; Song L; Yan X
    Neuroscience; 2013 Apr; 235():16-26. PubMed ID: 23333866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma and cerebrospinal fluid inflammation and the blood-brain barrier in older surgical patients: the Role of Inflammation after Surgery for Elders (RISE) study.
    Vasunilashorn SM; Ngo LH; Dillon ST; Fong TG; Carlyle BC; Kivisäkk P; Trombetta BA; Vlassakov KV; Kunze LJ; Arnold SE; Xie Z; Inouye SK; Libermann TA; Marcantonio ER;
    J Neuroinflammation; 2021 Apr; 18(1):103. PubMed ID: 33931093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluid proteomics of CSF and serum reveal important neuroinflammatory proteins in blood-brain barrier disruption and outcome prediction following severe traumatic brain injury: a prospective, observational study.
    Lindblad C; Pin E; Just D; Al Nimer F; Nilsson P; Bellander BM; Svensson M; Piehl F; Thelin EP
    Crit Care; 2021 Mar; 25(1):103. PubMed ID: 33712077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble CD146 displays angiogenic properties and promotes neovascularization in experimental hind-limb ischemia.
    Harhouri K; Kebir A; Guillet B; Foucault-Bertaud A; Voytenko S; Piercecchi-Marti MD; Berenguer C; Lamy E; Vely F; Pisano P; Ouafik L; Sabatier F; Sampol J; Bardin N; Dignat-George F; Blot-Chabaud M
    Blood; 2010 May; 115(18):3843-51. PubMed ID: 20185588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble CD146 Is a Novel Marker of Systemic Congestion in Heart Failure Patients: An Experimental Mechanistic and Transcardiac Clinical Study.
    Arrigo M; Truong QA; Onat D; Szymonifka J; Gayat E; Tolppanen H; Sadoune M; Demmer RT; Wong KY; Launay JM; Samuel JL; Cohen-Solal A; Januzzi JL; Singh JP; Colombo PC; Mebazaa A
    Clin Chem; 2017 Jan; 63(1):386-393. PubMed ID: 28062630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Association between serum soluble CD146 level and plaque vulnerability in carotid atherosclerosis].
    Qian Y; Lin J; Duan H; Luo Y; Feng L
    Zhonghua Yi Xue Za Zhi; 2014 Nov; 94(43):3392-6. PubMed ID: 25622668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical value of circulating endothelial cells and of soluble CD146 levels in patients undergoing surgery for non-small cell lung cancer.
    Ilie M; Long E; Hofman V; Selva E; Bonnetaud C; Boyer J; Vénissac N; Sanfiorenzo C; Ferrua B; Marquette CH; Mouroux J; Hofman P
    Br J Cancer; 2014 Mar; 110(5):1236-43. PubMed ID: 24473396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokine and immune cell profiling in the cerebrospinal fluid of patients with neuro-inflammatory diseases.
    Lepennetier G; Hracsko Z; Unger M; Van Griensven M; Grummel V; Krumbholz M; Berthele A; Hemmer B; Kowarik MC
    J Neuroinflammation; 2019 Nov; 16(1):219. PubMed ID: 31727097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood-brain barrier breakdown, neuroinflammation, and cognitive decline in older adults.
    Bowman GL; Dayon L; Kirkland R; Wojcik J; Peyratout G; Severin IC; Henry H; Oikonomidi A; Migliavacca E; Bacher M; Popp J
    Alzheimers Dement; 2018 Dec; 14(12):1640-1650. PubMed ID: 30120040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated serum levels of soluble CD146 in patients with systemic sclerosis.
    Ito T; Tamura N; Okuda S; Tada K; Matsushita M; Yamaji K; Kato K; Takasaki Y
    Clin Rheumatol; 2017 Jan; 36(1):119-124. PubMed ID: 27726047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelial cell adhesion molecule CD146: implications for its role in the pathogenesis of COPD.
    Kratzer A; Chu HW; Salys J; Moumen Z; Leberl M; Bowler R; Cool C; Zamora M; Taraseviciene-Stewart L
    J Pathol; 2013 Aug; 230(4):388-98. PubMed ID: 23649916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intercellular adhesion molecule-1 in cerebrospinal fluid--the evaluation of blood-derived and brain-derived fractions in neurological diseases.
    Lewczuk P; Reiber H; Tumani H
    J Neuroimmunol; 1998 Jul; 87(1-2):156-61. PubMed ID: 9670857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of Endothelial Cell Injury Marker Cd146 Correlates with Disease Severity and Predicts the Renal Outcomes in Patients with Diabetic Nephropathy.
    Fan Y; Fei Y; Zheng L; Wang J; Xiao W; Wen J; Xu Y; Wang Y; He L; Guan J; Wei J; He JC; Wang N
    Cell Physiol Biochem; 2018; 48(1):63-74. PubMed ID: 30001528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HMGB1 and thrombin mediate the blood-brain barrier dysfunction acting as biomarkers of neuroinflammation and progression to neurodegeneration in Alzheimer's disease.
    Festoff BW; Sajja RK; van Dreden P; Cucullo L
    J Neuroinflammation; 2016 Aug; 13(1):194. PubMed ID: 27553758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebrospinal Fluid and Blood Biomarkers of Neuroinflammation and Blood-Brain Barrier in Psychotic Disorders and Individually Matched Healthy Controls.
    Jeppesen R; Orlovska-Waast S; Sørensen NV; Christensen RHB; Benros ME
    Schizophr Bull; 2022 Nov; 48(6):1206-1216. PubMed ID: 35939296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of Multiple Variants of Soluble CD146 in Systemic Sclerosis: Identification of a Novel Profibrotic Factor.
    Nollet M; Bachelier R; Joshkon A; Traboulsi W; Mahieux A; Moyon A; Muller A; Somasundaram I; Simoncini S; Peiretti F; Leroyer AS; Guillet B; Granel B; Dignat-George F; Bardin N; Foucault-Bertaud A; Blot-Chabaud M
    Arthritis Rheumatol; 2022 Jun; 74(6):1027-1038. PubMed ID: 35001552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver X Receptor Alpha Is Important in Maintaining Blood-Brain Barrier Function.
    Wouters E; de Wit NM; Vanmol J; van der Pol SMA; van Het Hof B; Sommer D; Loix M; Geerts D; Gustafsson JA; Steffensen KR; Vanmierlo T; Bogie JFJ; Hendriks JJA; de Vries HE
    Front Immunol; 2019; 10():1811. PubMed ID: 31417573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble CD146 boosts therapeutic effect of endothelial progenitors through proteolytic processing of short CD146 isoform.
    Stalin J; Harhouri K; Hubert L; Garrigue P; Nollet M; Essaadi A; Muller A; Foucault-Bertaud A; Bachelier R; Sabatier F; Pisano P; Peiretti F; Leroyer AS; Guillet B; Bardin N; Dignat-George F; Blot-Chabaud M
    Cardiovasc Res; 2016 Aug; 111(3):240-51. PubMed ID: 27170199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.